Cytomegalovirus immediate-early protein 1 peptide–Major Histocompatibility Complex class I complex (CMV IE-1–MHC I complex)

The Cytomegalovirus (CMV) immediate-early protein 1 (IE-1) peptide–Major Histocompatibility Complex (MHC) class I complex is a primary immunological target for the cellular immune response against Human Cytomegalovirus (HCMV). IE-1, encoded by the UL123 gene, is among the first viral proteins synthesized following infection or reactivation from latency, making it a critical early signal for the immune system (PMID: 25653438). Peptides derived from IE-1, such as the immunodominant VLEETSVML peptide, are processed and presented on the cell surface by MHC class I molecules (typically HLA-A*02:01 in humans). This presentation allows for the specific recognition and activation of CD8+ cytotoxic T lymphocytes (CTLs), which are essential for controlling viral replication and preventing clinical disease in immunocompromised individuals. In therapeutic development, this complex is targeted by adoptive T-cell therapies and TCR-engineered T cells (TCR-T) designed to restore CMV-specific immunity in hematopoietic stem cell or solid organ transplant recipients. Additionally, several vaccine candidates utilize IE-1 sequences to elicit robust T-cell responses. Because CMV has evolved numerous mechanisms to downregulate MHC class I expression to evade detection, therapeutic strategies often focus on enhancing the sensitivity of T cells to low-density IE-1–MHC complexes on the surface of infected cells (PMID: 11812997). Understanding the structural interaction between the IE-1 peptide and specific HLA alleles is vital for the design of precision immunotherapies and diagnostic tetramer assays.

Other names

HCMV IE1 peptide-HLA complexUL123 peptide-MHC complexIE1-HLA-A*02:01 complexCMV IE1-MHCImmediate-early protein 1 antigen-MHC complex

The complex is recognized by the T-cell receptor (TCR) of CD8+ cytotoxic T lymphocytes, which triggers the release of cytotoxic granules (perforin/granzyme) and cytokines like IFN-gamma to eliminate infected cells (PMID: 15650015).